Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
14
2012
Two Connecticut-based Companies Recognized by EPA as Top Green Power Partners U.S. Environmental Protection Agency
Aug
12
2012
EPA Announces Funding for Research to Improve Air Quality, Protect Health U.S. Environmental Protection Agency
Aug
11
2012
EPA Awards $2 Million to Small Businesses to Support Environmental Innovation, Protect Health U.S. Environmental Protection Agency
Aug
9
2012
Michigan Energy: 25 x 25 Ballot Petitions Filed for November Vote Varnum LLP
Aug
9
2012
$7B in Contracting Opportunities for Renewable Energy Projects Morgan, Lewis & Bockius LLP
Aug
7
2012
Managing Green Product Claims and Expectations Dinsmore & Shohl LLP
Aug
7
2012
Tremendous Transactional Opportunities in Life Sciences / Healthcare Faegre Drinker
Aug
6
2012
New Massachusetts Law Boosts Wind and Solar Energy Mintz
Jul
26
2012
Wind Turbine Tax Assessment Confusion Varnum LLP
Jul
26
2012
Department of Interior Secretary Endorses Federal Regulation of Hydraulic Fracturing McDermott Will & Emery
Jul
25
2012
Are Genes Patentable? Myriad Revisited ArentFox Schiff LLP
Jul
25
2012
Pollution Pact in Wisconsin: U.S. EPA Issues Fines, Orders Upgrades at Coal-Fired Power Plants Center for Public Integrity
Jul
25
2012
Oral Arguments Heard By Federal Circuit in Myriad Gene Patent Case Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jul
21
2012
EPA Provides $950,000 to Improve Water Quality Using Green Infrastructure in 17 Communities U.S. Environmental Protection Agency
Jul
16
2012
Massachusetts Amends Its Drug and Device Marketing Law Faegre Drinker
Jul
12
2012
New Biodiesel Plant to Start Up This Summer Varnum LLP
Jul
11
2012
The Myriad Decision in the U.S. Supreme Court Hunton Andrews Kurth
Jul
11
2012
Patent Trends (or Lack thereof) in Green Energy Technology Hunton Andrews Kurth
Jul
9
2012
What Is an “Abstract Idea”? Who’s on First? What’s on Second? McDermott Will & Emery
Jul
8
2012
Michigan Tech Increases the Efficiency of Solar Cells Varnum LLP
Jul
4
2012
Wind Farm Approved for Mason County, Michigan Varnum LLP
Jul
3
2012
New Battery Technology from A123 Varnum LLP
Jul
3
2012
Compensation for Energy Workers, $8 Billion and Counting U.S. Department of Labor
Jun
29
2012
U.S. Supreme Court’s Affordable Care Act Decision: Impacts on Life Sciences Faegre Drinker
Jun
28
2012
“Obamacare” Survives – Including Path to Generic Biologicals Schwegman, Lundberg & Woessner, P.A.
Jun
28
2012
Lilly Files Amicus Brief in Myriad Remand – With Friends Like This… Schwegman, Lundberg & Woessner, P.A.
Jun
26
2012
New FDA Informed Consent Requirements for Applicable Clinical Trials: Practical Approaches for Implementation Faegre Drinker
Jun
25
2012
World’s First Stem-Cell Drug Approval Achieved in Canada Faegre Drinker
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins